Purpose: This study aimed to assess self-reported satisfaction following cataract surgery, and the sustainability of improved visual function and health-related quality of life in a cataract surgical cohort over 3 years post-phacoemulsification surgery.
Design: A clinic-based cohort study.
Methods: Cataract surgical patients were recruited and followed up annually after surgery.
Purpose: To compare mortality risk between cataract surgical patients with corrected and persistent visual impairment.
Design: Cohort study.
Methods: A total of 1864 consecutive patients, aged ≥64 years, undergoing phacoemulsification surgery at Westmead Hospital were followed annually for 5 years postoperatively.
Purpose: To assess 3-year incidence and associated factors of posterior capsule opacification (PCO) after phacoemulsification surgery.
Design: Cohort study.
Methods: A total of 1934 consecutive patients aged ≥64 years undergoing phacoemulsification surgery at Westmead Hospital were recruited, of whom 1495 (77.
Purpose: To describe the change in visual acuity (VA) and incidence of visual impairment (VI) in an older population over a 15-year period.
Design: Population-based cohort.
Participants: Of the 3654 participants of the Blue Mountains Eye Study (BMES) baseline examination from 1992 through 1994, 1149 were re-examined during the 15-year follow-up between 2007 and 2010.
Purpose: To assess the impact of visual impairment and blindness on the incident use of community support services in the Blue Mountains Eye Study.
Design: Population-based cohort.
Methods: Of 3654 baseline participants (1992-1994), 2334, 1952, and 1149 were re-examined after 5, 10, and 15 years, respectively.
Objective: We assessed whether correction of visual impairment (VI) by cataract surgery was associated with improved long-term survival in an older Australian population.
Design: Population-based cohort study.
Participants: In the Blue Mountains Eye Study, 354 participants, aged ≥ 49 years, had both cataract and VI or had undergone cataract surgery before baseline examinations.
Purpose: To assess eye-specific epiretinal membrane (ERM) incidence 3 years after phacoemulsification surgery, and ERM detection bias attributable to cataract.
Design: Cohort study.
Methods: We recruited 1932 cataract surgical patients aged ≥64 years at Westmead Hospital (2004-2007).
Objective: To clarify possible associations between cataract surgery and progression of age-related macular degeneration (AMD).
Design: Clinic-based cohort.
Participants: We followed cataract surgical patients aged 65+ years in the Australian Cataract Surgery and Age-related Macular Degeneration (CSAMD) study.
Background: It is unclear whether differences exist in surgical complication rates and long-term visual acuity outcomes between patients whose phacoemulsification cataract surgery was performed by ophthalmological trainees and those performed by consultants.
Design: Prospective clinical cohort study.
Participants: 1851 participants of the Cataract Surgery and Age-related Macular Degeneration study, aged ≥64 years, had cataract surgery performed at Westmead Hospital, Sydney.
Purpose: To assess whether improved visual acuity (VA) is sustained 2 years after the cataract surgery.
Methods: The Cataract Surgery and Age-Related Macular Degeneration (CSAMD) study followed 1936 patients aged ≥ 65 years undergoing phacoemulsification cataract surgery at Westmead Hospital (Sydney, Australia) between 2004 and 2007. Presenting and pinhole VA were assessed and retinal photography was performed annually.
Purpose: To assess cataract surgery visual outcomes 12 months postoperatively in patients with diabetes, with or without diabetic retinopathy (DR), compared to patients without diabetes.
Methods: We followed 1192 cataract surgical patients aged ≥65 for 12 months postoperatively. Standardised pre- and postoperative pinhole LogMAR visual acuity (VA) measurements were taken.
Purpose: To assess changes in the pattern of eye care utilization among older Australians with correctable visual impairment, identified in an eye survey.
Methods: The Blue Mountains Eye Study (BMES) examined 3654 Australians aged >or= 49 years at baseline (BMES-I). Five-year follow-up examinations were attended by 2334 participants, 75.